Life science industries step up efforts to combat climate change

As political leaders from around the world get ready to meet at the COP 28 climate conference, life science companies are taking steps to encourage sustainability within industry.

Companies from across the global healthcare sector, including AstraZeneca (LSE: AZN), GSK (LSE: GSK), Novo Nordisk (NOV: N) and Roche (ROG: SIX), are working together on initiatives to reduce carbon emissions to zero.

The discussions are taking place under the aegis of the Sustainable Markets Initiative (SMI), a non-profit group launched in 2020 by the British King, Charles III, with a mission to “kickstart bold and imaginative action across the next decade.”